Cos. Say China Blocked Vitamin C Antitrust Suit Compliance – Law360 (subscription)

Law360, New York (April 17, 2015, 7:04 PM ET) — Two Chinese companies urged a New York federal judge Friday to deny a bid by a group of U.S. businesses to sanction them for refusing to turn over financial documents in a vitamin C price-fixing suit, saying the Chinese government has prohibited them from doing so.

North China Pharmaceutical Group Corp. and its vitamin C unit, HeBei Welcome Pharmaceutical Co. Ltd. — which were hit with a verdict topping $150 million — rejected arguments made by the businesses that they have flouted the judge’s October discovery…


Write a Reply or Comment:

Your email address will not be published.*